Current position13 Jul 2018 12:20
I still think that CLIN represents excellent value for EPS growth. Acquisitions such as Quantum, Idis and IMMC are yet to fully contribute and once these are fully consolidated and integrated with the Group and operational costs are cut further, CLIN really has the potential to grow organically and achieve its economies of scale.